RIM
BMY icon

Regent Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Regent Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$6.9M Sell
95,901
-1,110
-1% -$83.7K 1.85% 11
2022
Q3 		$6.9M Buy
97,011
+520
+0.5% +$37.7K 2.01% 10
2022
Q2 		$7.43M Sell
96,491
-1,030
-1% -$78.4K 2.07% 11
2022
Q1 		$7.12M Sell
97,521
-765
-0.8% -$51.4K 1.65% 13
2021
Q4 		$6.13M Sell
98,286
-3,935
-4% -$231K 1.34% 16
2021
Q3 		$6.05M Buy
102,221
+1,095
+1% +$72.1K 1.45% 14
2021
Q2 		$6.76M Buy
101,126
+1,735
+2% +$113K 1.58% 12
2021
Q1 		$6.28M Buy
99,391
+2,425
+3% +$151K 1.58% 13
2020
Q4 		$6.01M Sell
96,966
-2,820
-3% -$173K 1.67% 12
2020
Q3 		$6.02M Buy
99,786
+1,635
+2% +$98.4K 1.86% 13
2020
Q2 		$5.77M Buy
98,151
+8,560
+10% +$512K 1.92% 12
2020
Q1 		$4.99M Buy
89,591
+10,005
+13% +$612K 2.06% 10
2019
Q4 		$5.11M Buy
79,586
+62,034
+353% +$3.55M 1.56% 14
2019
Q3 		$890K Sell
17,552
-300
-2% -$14.1K 0.29% 92
2019
Q2 		$810K Hold
17,852
– – 0.26% 101
2019
Q1 		$852K Sell
17,852
-275
-2% -$13.7K 0.28% 93
2018
Q4 		$943K Hold
18,127
– – 0.35% 80
2018
Q3 		$1.13M Hold
18,127
– – 0.35% 78
2018
Q2 		$1M Sell
18,127
-10,920
-38% -$590K 0.34% 82
2018
Q1 		$1.84M Buy
29,047
+3,795
+15% +$244K 0.62% 53
2017
Q4 		$1.55M Buy
25,252
+9,025
+56% +$564K 0.51% 61
2017
Q3 		$1.03M Hold
16,227
– – 0.35% 87
2017
Q2 		$904K Sell
16,227
-3,505
-18% -$191K 0.32% 90
2017
Q1 		$1.07M Sell
19,732
-1,550
-7% -$85K 0.41% 78
2016
Q4 		$1.24M Sell
21,282
-1,675
-7% -$91.6K 0.64% 44
2016
Q3 		$1.24M Sell
22,957
-1,800
-7% -$116K 0.64% 45
2016
Q2 		$1.82M Buy
24,757
+1,222
+5% +$86.3K 0.99% 29
2016
Q1 		$1.5M Buy
23,535
+900
+4% +$56.8K 0.84% 36
2015
Q4 		$1.56M Sell
22,635
-1,492
-6% -$98.6K 0.83% 31
2015
Q3 		$1.43M Buy
24,127
+6,552
+37% +$416K 0.79% 36
2015
Q2 		$1.17M Buy
17,575
+600
+4% +$39.5K 0.59% 47
2015
Q1 		$1.09M Buy
16,975
+2,700
+19% +$169K 0.56% 54
2014
Q4 		$843K Sell
14,275
-3,500
-20% -$197K 0.43% 69
2014
Q3 		$910K Sell
17,775
-1,570
-8% -$78.4K 0.47% 70
2014
Q2 		$938K Sell
19,345
-600
-3% -$29.6K 0.46% 69
2014
Q1 		$1.04M Hold
19,945
– – 0.55% 62
2013
Q4 		$1.06M Buy
19,945
+14,275
+252% +$727K 0.59% 55
2013
Q3 		$262K Buy
+5,670
New +$249K 0.17% 137

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Regent Investment Management's BMY Position: Q4 2022 in Review

Regent Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q4 2022, selling an estimated $83.7K and leaving 95,901 shares worth $6.9M. The position accounts for 1.85% of the portfolio, ranked #11.

Regent Investment Management first reported a position in BMY in Q3 2013 and has held it in 38 quarters since. The position peaked at $7.43M in Q2 2022. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Regent Investment Management held 95,901 shares of Bristol-Myers Squibb worth $6.9M as of Q4 2022.
  • Regent Investment Management sold 1,110 Bristol-Myers Squibb shares in Q4 2022, an estimated $83.7K.
  • Bristol-Myers Squibb made up 1.85% of Regent Investment Management's portfolio in Q4 2022, its #11 holding.
  • Regent Investment Management first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 38 quarters since.
  • Regent Investment Management's Bristol-Myers Squibb position peaked at $7.43M in Q2 2022.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Regent Investment Management's 13F filing for Q4 2022, filed 26 Jan 2023.